GlassScriptPhysician profile
Munib S Mafazy
NPI 1588859169
$1,068.60
in general payments reported to CMS, 2019-2025
19 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $400 · 2023: $55.17 · 2024: $449 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.67 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $228.15 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $150.00 | 2024 | Ultomiris |
| Lundbeck LLC | $122.52 | 2024 | Vyepti |
| E.R. Squibb & Sons, L.L.C. | $111.14 | 2024 | Zeposia |
| Biogen, INC. | $85.74 | 2022 | |
| Livanova USA, INC. | $59.13 | 2022-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Genzyme Corporation | $45.32 | 2025 | |
| Merz Pharmaceuticals, LLC | $42.22 | 2025 | Inbrija |
| Pfizer INC. | $34.97 | 2024 | |
| Celgene Corporation | $30.42 | 2022-2023 | Zeposia |
| Tg Therapeutics, INC. | $24.54 | 2025 | |
| Amneal Pharmaceuticals LLC | $21.73 | 2022 | |
| Corium, LLC | $19.82 | 2022 | |
| Impel Pharmaceuticals INC. | $18.91 | 2023 | Trudhesa |
| Jazz Pharmaceuticals INC. | $16.47 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $15.59 | 2022 | |
| Almatica Pharma LLC | $15.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.67 | 2024 | |
| Genentech USA, INC. | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munib Mafazy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.